Spinal fluid test may aid early detection of Parkinson's disease - NewsChannel5.com | Nashville News, Weather & Sports

Spinal fluid test may aid early detection of Parkinson's disease

Updated:
© iStockphoto.com / Thinkstock © iStockphoto.com / Thinkstock

TUESDAY, Aug. 27 (HealthDay News) -- Testing for certain proteins in spinal fluid may help doctors diagnose Parkinson's disease earlier and determine how fast the movement disorder is likely to advance, according to new research.

The team from the Perelman School of Medicine at the University of Pennsylvania said their discovery of these protein "biomarkers" might also aid in the development of new Parkinson's treatments.

"Biomarkers for Parkinson's disease such as these could help us diagnose patients earlier," study senior author Leslie Shaw, a professor of pathology and laboratory medicine at Penn Medicine, said in a university news release.

Shaw and Dr. John Trojanowski are co-leaders in the bioanalytics core for the Parkinson's Progression Markers Initiative (PPMI), an international study sponsored by The Michael J. Fox Foundation for Parkinson's. They led a team that collected spinal fluid from 102 people. Of these, 63 had early, untreated Parkinson's disease and 39 did not have the disorder (the "control" group).

The investigators examined the levels of five specific substances in the spinal fluid, including amyloid beta, total tau, phosphorylated tau, alpha synuclein and the ratio of total tau to amyloid beta.

The findings revealed that, compared with the healthy control group, people with early stage Parkinson's had lower levels of amyloid beta, tau and alpha synuclein in their spinal fluid.

In addition, patients with lower levels of tau and alpha synuclein had more problems with movement, the study authors noted in the report published Aug. 26 in JAMA Neurology.

The researchers found that patients with early stage Parkinson's and low levels of amyloid beta and tau were more likely to experience falls, freezing and trouble walking. Previous research has shown that this type of motor dysfunction in Parkinson's is associated with more functional disability and a faster decline in thinking skills.

"We are hoping to identify subgroups of Parkinson's patients whose disease is likely to progress at a different rate, as early as possible," noted Trojanowski, who is also director of the Penn Udall Center for Parkinson's Research. "Early prediction is critical, for both motor and dementia symptoms," he said in the news release.

PPMI trial site study leader and professor of neurology, Dr. Matthew Stern, added in the news release that "in addition to biomarker tests, validating risk factors could enable earlier detection of the disease and open new avenues in the quest for therapies that could slow or stop disease progression." Stern is also director of Penn's Parkinson's Disease and Movement Disorders Center.

The study authors pointed out that more research is needed to evaluate and confirm the spinal fluid testing procedure.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on Parkinson's disease.

Copyright © 2013 HealthDay. All rights reserved.

  • Medical News HeadlinesMedical News HeadlinesMore>>

  • Growing Stem Cells In Space?

    Growing Stem Cells In Space?

    Wednesday, April 23 2014 5:15 PM EDT2014-04-23 21:15:09 GMT
    Hemorrhagic stroke is responsible for more than 30 percent of all stroke deaths. It happens when a weakened blood vessel ruptures and bleeds into the brain.more>>
    Hemorrhagic stroke is responsible for more than 30 percent of all stroke deaths. It happens when a weakened blood vessel ruptures and bleeds into the brain.more>>
  • New Laser Treatment Stops Some Epileptic Seizures

    New Laser Treatment Stops Some Epileptic Seizures

    Tuesday, April 22 2014 6:00 PM EDT2014-04-22 22:00:21 GMT
    More than two million adults in the United States have epilepsy and 150,000 more will develop the condition each year. Usually, medication can control seizures, but about 30 percent of patients do not respond. Now, patients have a new treatment option that uses lasers to stop the seizures.
    more>>
    More than two million adults in the United States have epilepsy and 150,000 more will develop the condition each year. Usually, medication can control seizures, but about 30 percent of patients do not respond. Now, patients have a new treatment option that uses lasers to stop the seizures.

    more>>
  • Heating Up Breast Cancer

    Heating Up Breast Cancer

    Monday, April 21 2014 6:15 PM EDT2014-04-21 22:15:09 GMT
    Two years ago, doctors told Lisa Ridgeway she had triple negative breast cancer, a very aggressive disease with no cure. Lisa had surgery, radiation, and chemo, but her cancer came back two more times. Now she’s trying something new.
    more>>
    Two years ago, doctors told Lisa Ridgeway she had triple negative breast cancer, a very aggressive disease with no cure. Lisa had surgery, radiation, and chemo, but her cancer came back two more times. Now she’s trying something new.

    more>>
  • Migraine Relief: Stopping Pain & Relieving Pressure

    Migraine Relief: Stopping Pain & Relieving Pressure

    Friday, April 18 2014 5:15 PM EDT2014-04-18 21:15:06 GMT
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
  • Hope For Lanie: Curing SMA

    Hope For Lanie: Curing SMA

    Thursday, April 17 2014 5:15 PM EDT2014-04-17 21:15:09 GMT
    SMA attacks the body's motor neurons and causes paralysis. There is no cure, but for the first time doctors are studying an experimental therapy that targets more than just symptoms.more>>
    SMA attacks the body's motor neurons and causes paralysis. There is no cure for SMA but for the first time doctors are studying an experimental therapy that targets more than just symptoms, it targets mutated SMN genes, which are responsible for SMA.more>>
  • Washing Lungs & Breathing Better

    Washing Lungs & Breathing Better

    Wednesday, April 16 2014 5:15 PM EDT2014-04-16 21:15:09 GMT
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
  • Ocular Melanoma: Saving Lives, Saving Eyes

    Ocular Melanoma: Saving Lives, Saving Eyes

    Friday, April 11 2014 5:15 PM EDT2014-04-11 21:15:07 GMT
    Ocular melanoma, also called uveal melanoma, is a rare type of melanoma that targets the eye. It can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
    Ocular melanoma, also called uveal melanoma, is a type of melanoma that targets the eye. It affects about 2,000 people a year in the United States. Although rare – it can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
  • Memory Palace: Coping With Chemo Brain

    Memory Palace: Coping With Chemo Brain

    Thursday, April 10 2014 5:15 PM EDT2014-04-10 21:15:09 GMT
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
  • Pedaling For A Cure

    Pedaling For A Cure

    Wednesday, April 9 2014 5:15 PM EDT2014-04-09 21:15:09 GMT
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
  • Bringing Hearts Back To Life: New Improved Defibrillator

    Bringing Hearts Back To Life: New Improved Defibrillator

    Tuesday, April 8 2014 5:15 PM EDT2014-04-08 21:15:13 GMT
    CPR and a portable defibrillator helped keep Eric Robinson alive after he went into cardiac arrest. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
    A year ago, while jamming with his son's band, Eric Robinson went into cardiac arrest. CPR and a portable defibrillator helped keep Robinson alive. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
Powered by WorldNow
All content © Copyright 2000 - 2014 NewsChannel 5 (WTVF-TV) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.